News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
759,818 Results
Type
Article (46210)
Company Profile (332)
Press Release (713251)
Multimedia
Podcasts (161)
Webinars (25)
Section
Business (213181)
Career Advice (2211)
Deals (37324)
Drug Delivery (154)
Drug Development (84807)
Employer Resources (178)
FDA (17101)
Job Trends (15720)
News (361939)
Policy (34683)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2675)
Accelerated approval (49)
Adcomms (37)
Allergies (180)
Alliances (52230)
ALS (221)
Alzheimer's disease (1848)
Antibody-drug conjugate (ADC) (493)
Approvals (17467)
Artificial intelligence (719)
Autoimmune disease (307)
Automation (57)
Bankruptcy (379)
Best Places to Work (11840)
BIOSECURE Act (22)
Biosimilars (236)
Biotechnology (191)
Bladder cancer (198)
Brain cancer (76)
Breast cancer (776)
Cancer (6052)
Cardiovascular disease (513)
Career advice (1875)
Career pathing (48)
CAR-T (346)
CDC (64)
Celiac Disease (3)
Cell therapy (947)
Cervical cancer (47)
Clinical research (73526)
Collaboration (2191)
Company closure (6)
Compensation (1439)
Complete response letters (95)
COVID-19 (2842)
CRISPR (116)
C-suite (1186)
Cystic fibrosis (158)
Data (8106)
Decentralized trials (3)
Denatured (46)
Depression (171)
Dermatology (89)
Diabetes (612)
Diagnostics (7064)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (342)
Drug pricing (236)
Drug shortages (37)
Duchenne muscular dystrophy (294)
Earnings (94365)
Editorial (72)
Employer branding (21)
Employer resources (158)
Events (123957)
Executive appointments (1127)
FDA (20923)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1780)
Gene editing (249)
Generative AI (64)
Gene therapy (768)
GLP-1 (1182)
Government (4967)
Grass and pollen (7)
Guidances (410)
Healthcare (19356)
HIV (83)
Huntington's disease (57)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (101)
Immunology and inflammation (326)
Immuno-oncology (101)
Indications (197)
Infectious disease (3200)
Inflammatory bowel disease (228)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (297)
Interviews (348)
IPO (17115)
IRA (58)
Job creations (4181)
Job search strategy (1565)
JPM (71)
Kidney cancer (21)
Labor market (103)
Layoffs (622)
Leadership (48)
Legal (8584)
Liver cancer (102)
Longevity (33)
Lung cancer (797)
Lymphoma (437)
Machine learning (62)
Management (62)
Manufacturing (1114)
MASH (203)
Medical device (14082)
Medtech (14210)
Mergers & acquisitions (21471)
Metabolic disorders (1640)
mRNA (225)
Multiple sclerosis (196)
NASH (21)
Neurodegenerative disease (445)
Neuropsychiatric disorders (116)
Neuroscience (3433)
Neurotech (1)
NextGen: Class of 2026 (6738)
Non-profit (4606)
Now hiring (78)
Obesity (798)
Opinion (337)
Ovarian cancer (230)
Pain (278)
Pancreatic cancer (311)
Parkinson's disease (376)
Partnered (34)
Patents (614)
Patient recruitment (692)
Peanut (66)
People (62232)
Pharmaceutical (93)
Pharmacy benefit managers (36)
Phase 1 (22929)
Phase 2 (32307)
Phase 3 (24158)
Pipeline (9027)
Policy (354)
Postmarket research (2692)
Preclinical (9719)
Press Release (68)
Prostate cancer (315)
Psychedelics (58)
Radiopharmaceuticals (339)
Rare diseases (1149)
Real estate (6434)
Recruiting (72)
Regulatory (26747)
Reports (57)
Research institute (2488)
Resumes & cover letters (374)
Rett syndrome (39)
RNA editing (25)
RSV (96)
Schizophrenia (188)
Series A (299)
Series B (221)
Service/supplier (14)
Sickle cell disease (116)
Special edition (30)
Spinal muscular atrophy (173)
Sponsored (49)
Startups (3864)
State (2)
Stomach cancer (20)
Supply chain (135)
Tariffs (103)
The Weekly (112)
Vaccines (1155)
Venture capital (118)
Weight loss (545)
Women's health (130)
Worklife (21)
Date
Last 7 days (689)
Last 30 days (3307)
Last 365 days (30902)
2026 (13452)
2025 (31084)
2024 (36137)
2023 (40926)
2022 (52113)
2021 (56671)
2020 (55107)
2019 (47820)
2018 (36136)
2017 (33568)
2016 (33168)
2015 (39007)
2014 (32960)
2013 (28077)
2012 (30165)
2011 (30871)
2010 (28889)
Location
Africa (834)
Alabama (94)
Alaska (7)
Arizona (359)
Arkansas (16)
Asia (43664)
Australia (6955)
California (13526)
Canada (3838)
China (1434)
Colorado (575)
Connecticut (584)
Delaware (418)
Europe (94426)
Florida (2049)
Georgia (432)
Hawaii (3)
Idaho (62)
Illinois (1083)
India (93)
Indiana (619)
Iowa (23)
Japan (557)
Kansas (133)
Kentucky (50)
Louisiana (44)
Maine (76)
Maryland (1624)
Massachusetts (9690)
Michigan (370)
Minnesota (735)
Mississippi (6)
Missouri (145)
Montana (33)
Nebraska (29)
Nevada (147)
New Hampshire (84)
New Jersey (3568)
New Mexico (32)
New York (3536)
North Carolina (1772)
North Dakota (9)
Northern California (6775)
Ohio (405)
Oklahoma (24)
Oregon (47)
Pennsylvania (2718)
Puerto Rico (30)
Rhode Island (50)
South America (1201)
South Carolina (87)
South Dakota (2)
Southern California (5333)
Tennessee (217)
Texas (2161)
United States (47896)
Utah (403)
Vermont (1)
Virginia (341)
Washington D.C. (81)
Washington State (1079)
West Virginia (4)
Wisconsin (136)
Wyoming (2)
759,818 Results for "antares pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
C-suite
Lilly, J&J CEOs top pharma’s highest paid list—again
Three pharma CEOs joined the $30 million compensation club in 2025 but Eli Lilly’s David Ricks exceeded his nearest peer by more than $4 million.
May 13, 2026
·
5 min read
·
Annalee Armstrong
Press Releases
Arna Pharma Inc. and Slate Run Pharmaceuticals Finalize Joint Venture and Launch First Brand Product
May 14, 2026
·
3 min read
Press Releases
Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights
May 5, 2026
·
6 min read
FDA
FDA’s absent leaders, the millions pharma CEOs make, and pancreatic cancer’s momentum
Fallout from the resignation of FDA Commissioner Marty Makary continues as several other senior regulators are removed from their posts; pharma’s top paid CEOs make up to 358 times more than their employees; Revolution Medicine’s pancreatic cancer results highlight movement in the deadly disease space; more.
May 20, 2026
·
1 min read
·
Jef Akst
Press Releases
Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
May 14, 2026
·
1 min read
Press Releases
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
May 5, 2026
·
8 min read
Press Releases
Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor
May 13, 2026
·
8 min read
Opinion
Biotech can’t continue to innovate under strain of Big Pharma market pressures
Biotech is increasingly financed, governed and regulated as though it were a mature pharmaceutical industry rather than a discovery system built around scientific uncertainty. Structural changes are needed to sustain the sector’s strategic innovation.
May 19, 2026
·
5 min read
·
Jeremy Levin
Press Releases
Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026
April 20, 2026
·
8 min read
Government
RFK Jr. defends Makary, claims pharma ‘owns’ Congress and media
The pharma industry “own Congress, they own the media,” Health Secretary Robert F. Kennedy, Jr. told lawmakers by way of explaining the bad press against FDA Commissioner Marty Makary following the second rejection of Replimune’s advanced melanoma drug.
April 17, 2026
·
2 min read
·
Tristan Manalac
1 of 75,982
Next
